Monday #PreMarket Movers: Conatus Pharmaceuticals, Brainstorm Cell Therapeutics And More

Conatus Pharmaceuticals Inc (NASDAQ: CNAT) +40% - The company announced plans to report top-line results of its clinical trials of ...